1 November 2002 in The Journal of Thoracic and Cardiovascular Surgery
4 December 2017 in Cardiology in the Young
In many parts of the world, mostly low- and middle-income countries, timely diagnosis and repair of congenital heart diseases (CHDs) is not feasible for a variety of reasons. In these regions, economic growth has enabled the development of cardiac units that manage patients with CHD presenting later than would be ideal, often after the window for early stabilisation – transposition of the great arteries, coarctation of the aorta – or for lower-risk surgery in infancy – left-to-right shunts or cyanotic conditions. As a result, patients may have suffered organ dysfunction, manifest signs of pulmonary vascular disease, or the sequelae of profound cyanosis and polycythaemia. Late presentation poses unique clinical and ethical challenges in decision making regarding operability or surgical candidacy, surgical strategy, and perioperative intensive care management.
12 May 2017 in Pediatric Cardiology
MLMaria Isabel C. S. Lopes
+6
1 January 2017 in Brazilian Journal of Cardiovascular Surgery
1 November 2018 in International Journal of Cardiology
MSMarcelo Rodrigues dos Santos
Marcelo Rodrigues dos Santos
ASAna Luiza Carrari Sayegh
FSFrancis Ribeiro de Souza
DADaniela Regina Agostinho
MJMarcelo Biscegli Jatene
+8
1 January 2014 in Revista Brasileira de Terapia Intensiva
ELECMO group of the Hospital Sírio Libanês
ECMO group of the Hospital Sírio Libanês
HPHospital das Clínicas de São Paulo
Hospital das Clínicas de São Paulo
ETEvelinda Marramon Trindade
Evelinda Marramon Trindade
+8
To analyze the cost-utility of using extracorporeal oxygenation for patients with severe acute respiratory distress syndrome in Brazil. A decision tree was constructed using databases from previously published studies. Costs were taken from the average price paid by the Brazilian Unified Health System (Sistema Único de Saúde; SUS) over three months in 2011. Using the data of 10,000,000 simulated patients with predetermined outcomes and costs, an analysis was performed of the ratio between cost increase and years of life gained, adjusted for quality (cost-utility), with survival rates of 40 and 60% for patients using extracorporeal membrane oxygenation. The decision tree resulted in 16 outcomes with different life support techniques. With survival rates of 40 and 60%, respectively, the increased costs were R$=-301.00/-14.00, with a cost of R$=-30,913.00/-1,752.00 paid per six-month quality-adjusted life-year gained and R$=-2,386.00/-90.00 per quality-adjusted life-year gained until the end of life, when all patients with severe ARDS were analyzed. Analyzing only patients with severe hypoxemia (i.e., a ratio of partial oxygen pressure in the blood to the fraction of inspired oxygen <100 mmHg), the increased cost was R$=-5,714.00/272.00, with a cost per six-month quality-adjusted life-year gained of R$=-9,521.00/293.00 and a cost of R$=-280.00/7.00 per quality-adjusted life-year gained. The cost-utility ratio associated with the use of extracorporeal membrane oxygenation in Brazil is potentially acceptable according to this hypothetical study.